Delabeling Allergies in Hospitalized Patients – Medscape
The Promise of “Delabeling” for Hospitalized Allergy Sufferers
Table of Contents
For individuals hospitalized due to severe allergic reactions,the label of “allergic” can linger long after the immediate danger has passed,unnecessarily restricting their diet and lifestyle.Emerging research suggests a process called “delabeling” – carefully reintroducing previously avoided foods under medical supervision – may be a feasible and safe option for many, offering a path toward a more normal life.
Study Findings: A Glimmer of hope
A recent study presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024,examined the feasibility of delabeling in hospitalized patients. Researchers analyzed data from 18 centers across Europe, involving 388 patients hospitalized for severe allergic reactions to foods like milk, egg, wheat, and soy. The study, conducted between January 2018 and December 2023, revealed encouraging results.
The data showed that approximately 50% of patients were successfully delabeled for at least one food allergen. Specifically, 58% of those with milk allergies, 48% with egg allergies, 34% with wheat allergies, and 29% with soy allergies were able to tolerate the reintroduced foods without adverse effects. These findings were published in the Journal of Allergy and Clinical Immunology on August 26, 2024.
Who is a Good Candidate for Delabeling?
Delabeling isn’t suitable for everyone. The study highlighted that patients with a history of severe, life-threatening reactions (anaphylaxis) might potentially be at higher risk and require particularly cautious evaluation. Factors considered when determining candidacy include the severity of the initial reaction, the time elapsed since the reaction, and the patient’s overall health status.
According to Dr.Maria Moreno-Jiménez, lead author of the study, delabeling is most appropriate for patients who experienced a reaction a significant time ago and have remained symptom-free. It’s crucial to emphasize that this process must be conducted under the strict supervision of an allergist or immunologist in a setting equipped to manage potential anaphylactic reactions.
Delabeling offers a potential pathway to improve the quality of life for many patients, but it requires a careful and individualized approach.
The Delabeling Process: What to Expect
The delabeling process typically involves a phased approach:
- Initial Assessment: A thorough review of the patient’s medical history and allergy testing.
- Gradual Reintroduction: The allergen is introduced in very small, controlled doses, gradually increasing over time.
- Close Monitoring: Patients are closely monitored for any signs of an allergic reaction during and after each dose.
- Maintenance: If triumphant, patients are advised to continue consuming the allergen regularly to maintain tolerance.
The study noted that the majority of reactions, when they occurred, were mild to moderate, and easily managed with medication. However, the potential for a severe reaction always exists, underscoring the importance of medical supervision.